Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New COPD inhaler shows promise in Short-Term lung function test

NCT ID NCT06545500

First seen Feb 12, 2026 · Last updated May 24, 2026 · Updated 22 times

Summary

This study tested three different doses of an inhaled medication called glycopyrrolate in 46 adults with COPD. Participants used the drug twice daily for one week to see if it improved their lung function compared to a placebo. The goal was to find out how well it works and if it is safe for short-term use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • American Health Research Inc

    Charlotte, North Carolina, 28277, United States

  • Clinical Research of West Florida Inc - Clearwater

    Clearwater, Florida, 33765, United States

  • Clinical Research of West Florida Inc - Tampa

    Tampa, Florida, 33606, United States

  • Midwest Chest Consultants PC

    Saint Charles, Missouri, 63301, United States

  • Velocity Clinical Research - Greenville

    Greenville, South Carolina, 29615, United States

  • Velocity Clinical Research - Spartanburg

    Spartanburg, South Carolina, 29303, United States

  • Velocity Clinical Research - Union

    Union, South Carolina, 29379, United States

Conditions

Explore the condition pages connected to this study.